世界のデジタルコンパニオン診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Digital Companion Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1867 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、デジタルコンパニオン診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、イン・サイチュハイブリダイゼーション（ISH）、次世代シーケンシング（NGS））、用途別市場規模（病院、製薬会社、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・デジタルコンパニオン診断の市場動向 ・企業の競争状況、市場シェア ・デジタルコンパニオン診断の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、イン・サイチュハイブリダイゼーション（ISH）、次世代シーケンシング（NGS）） ・デジタルコンパニオン診断の用途別市場規模（病院、製薬会社、研究所、その他） ・デジタルコンパニオン診断の北米市場規模2016-2027（アメリカ、カナダ） ・デジタルコンパニオン診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・デジタルコンパニオン診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・デジタルコンパニオン診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・デジタルコンパニオン診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Holdings (Switzerland)、Abbott Laboratories (US)、Thermo Fisher Scientific (US)、Agilent Technologies (US)、Life Technologies (US)、GE Healthcare (UK)、Agendia (Angola)、Qiagen (Germany)、Genomic Health (US)、Myriad Genetics (US)、Advanced Cell Diagnostics (US)、Danaher (US)、Applied Proteomics (US)） ・結論

Market Analysis and Insights: Global Digital Companion Diagnostics Market
The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Companion Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Companion Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Companion Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Companion Diagnostics market.

Global Digital Companion Diagnostics Scope and Market Size
Digital Companion Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)

Segment by Application
Hospitals
Pharmaceutical Companies
Laboratories
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Holdings (Switzerland)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Life Technologies (US)
GE Healthcare (UK)
Agendia (Angola)
Qiagen (Germany)
Genomic Health (US)
Agilent Technologies (US)
Life Technologies (US)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Digital Companion Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Digital Companion Diagnostics Market Perspective (2016-2027)
2.2 Digital Companion Diagnostics Growth Trends by Regions
2.2.1 Digital Companion Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Digital Companion Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Digital Companion Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Digital Companion Diagnostics Industry Dynamic
2.3.1 Digital Companion Diagnostics Market Trends
2.3.2 Digital Companion Diagnostics Market Drivers
2.3.3 Digital Companion Diagnostics Market Challenges
2.3.4 Digital Companion Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Digital Companion Diagnostics Players by Revenue
3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue
3.4 Global Digital Companion Diagnostics Market Concentration Ratio
3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2020
3.5 Digital Companion Diagnostics Key Players Head office and Area Served
3.6 Key Players Digital Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Digital Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Digital Companion Diagnostics Breakdown Data by Type
4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2022-2027)

5 Digital Companion Diagnostics Breakdown Data by Application
5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Digital Companion Diagnostics Market Size (2016-2027)
6.2 North America Digital Companion Diagnostics Market Size by Type
6.2.1 North America Digital Companion Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Digital Companion Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Digital Companion Diagnostics Market Size by Type (2016-2027)
6.3 North America Digital Companion Diagnostics Market Size by Application
6.3.1 North America Digital Companion Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Digital Companion Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Digital Companion Diagnostics Market Size by Application (2016-2027)
6.4 North America Digital Companion Diagnostics Market Size by Country
6.4.1 North America Digital Companion Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Digital Companion Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Digital Companion Diagnostics Market Size (2016-2027)
7.2 Europe Digital Companion Diagnostics Market Size by Type
7.2.1 Europe Digital Companion Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Digital Companion Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Digital Companion Diagnostics Market Size by Type (2016-2027)
7.3 Europe Digital Companion Diagnostics Market Size by Application
7.3.1 Europe Digital Companion Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Digital Companion Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Digital Companion Diagnostics Market Size by Application (2016-2027)
7.4 Europe Digital Companion Diagnostics Market Size by Country
7.4.1 Europe Digital Companion Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Digital Companion Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Digital Companion Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Digital Companion Diagnostics Market Size by Type
8.2.1 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Application
8.3.1 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Digital Companion Diagnostics Market Size by Region
8.4.1 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Digital Companion Diagnostics Market Size (2016-2027)
9.2 Latin America Digital Companion Diagnostics Market Size by Type
9.2.1 Latin America Digital Companion Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Digital Companion Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Digital Companion Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Digital Companion Diagnostics Market Size by Application
9.3.1 Latin America Digital Companion Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Digital Companion Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Digital Companion Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Digital Companion Diagnostics Market Size by Country
9.4.1 Latin America Digital Companion Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Digital Companion Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Digital Companion Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Digital Companion Diagnostics Market Size by Type
10.2.1 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Application
10.3.1 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Digital Companion Diagnostics Market Size by Country
10.4.1 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Holdings (Switzerland)
11.1.1 Roche Holdings (Switzerland) Company Details
11.1.2 Roche Holdings (Switzerland) Business Overview
11.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Introduction
11.1.4 Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.1.5 Roche Holdings (Switzerland) Recent Development
11.2 Abbott Laboratories (US)
11.2.1 Abbott Laboratories (US) Company Details
11.2.2 Abbott Laboratories (US) Business Overview
11.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Introduction
11.2.4 Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.2.5 Abbott Laboratories (US) Recent Development
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Details
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Introduction
11.3.4 Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.3.5 Thermo Fisher Scientific (US) Recent Development
11.4 Agilent Technologies (US)
11.4.1 Agilent Technologies (US) Company Details
11.4.2 Agilent Technologies (US) Business Overview
11.4.3 Agilent Technologies (US) Digital Companion Diagnostics Introduction
11.4.4 Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.4.5 Agilent Technologies (US) Recent Development
11.5 Life Technologies (US)
11.5.1 Life Technologies (US) Company Details
11.5.2 Life Technologies (US) Business Overview
11.5.3 Life Technologies (US) Digital Companion Diagnostics Introduction
11.5.4 Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.5.5 Life Technologies (US) Recent Development
11.6 GE Healthcare (UK)
11.6.1 GE Healthcare (UK) Company Details
11.6.2 GE Healthcare (UK) Business Overview
11.6.3 GE Healthcare (UK) Digital Companion Diagnostics Introduction
11.6.4 GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.6.5 GE Healthcare (UK) Recent Development
11.7 Agendia (Angola)
11.7.1 Agendia (Angola) Company Details
11.7.2 Agendia (Angola) Business Overview
11.7.3 Agendia (Angola) Digital Companion Diagnostics Introduction
11.7.4 Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.7.5 Agendia (Angola) Recent Development
11.8 Qiagen (Germany)
11.8.1 Qiagen (Germany) Company Details
11.8.2 Qiagen (Germany) Business Overview
11.8.3 Qiagen (Germany) Digital Companion Diagnostics Introduction
11.8.4 Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.8.5 Qiagen (Germany) Recent Development
11.9 Genomic Health (US)
11.9.1 Genomic Health (US) Company Details
11.9.2 Genomic Health (US) Business Overview
11.9.3 Genomic Health (US) Digital Companion Diagnostics Introduction
11.9.4 Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.9.5 Genomic Health (US) Recent Development
11.10 Myriad Genetics (US)
11.10.1 Myriad Genetics (US) Company Details
11.10.2 Myriad Genetics (US) Business Overview
11.10.3 Myriad Genetics (US) Digital Companion Diagnostics Introduction
11.10.4 Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.10.5 Myriad Genetics (US) Recent Development
11.11 Advanced Cell Diagnostics (US)
11.11.1 Advanced Cell Diagnostics (US) Company Details
11.11.2 Advanced Cell Diagnostics (US) Business Overview
11.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Introduction
11.11.4 Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.11.5 Advanced Cell Diagnostics (US) Recent Development
11.12 Danaher (US)
11.12.1 Danaher (US) Company Details
11.12.2 Danaher (US) Business Overview
11.12.3 Danaher (US) Digital Companion Diagnostics Introduction
11.12.4 Danaher (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.12.5 Danaher (US) Recent Development
11.13 Applied Proteomics (US)
11.13.1 Applied Proteomics (US) Company Details
11.13.2 Applied Proteomics (US) Business Overview
11.13.3 Applied Proteomics (US) Digital Companion Diagnostics Introduction
11.13.4 Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2016-2021)
11.13.5 Applied Proteomics (US) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Digital Companion Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Digital Companion Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Digital Companion Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Digital Companion Diagnostics Market Share by Regions (2022-2027)
Table 12. Digital Companion Diagnostics Market Trends
Table 13. Digital Companion Diagnostics Market Drivers
Table 14. Digital Companion Diagnostics Market Challenges
Table 15. Digital Companion Diagnostics Market Restraints
Table 16. Global Digital Companion Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Digital Companion Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2020)
Table 19. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Digital Companion Diagnostics Product Solution and Service
Table 23. Date of Enter into Digital Companion Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Digital Companion Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Digital Companion Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Digital Companion Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Holdings (Switzerland) Company Details
Table 64. Roche Holdings (Switzerland) Business Overview
Table 65. Roche Holdings (Switzerland) Digital Companion Diagnostics Product
Table 66. Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Roche Holdings (Switzerland) Recent Development
Table 68. Abbott Laboratories (US) Company Details
Table 69. Abbott Laboratories (US) Business Overview
Table 70. Abbott Laboratories (US) Digital Companion Diagnostics Product
Table 71. Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Abbott Laboratories (US) Recent Development
Table 73. Thermo Fisher Scientific (US) Company Details
Table 74. Thermo Fisher Scientific (US) Business Overview
Table 75. Thermo Fisher Scientific (US) Digital Companion Diagnostics Product
Table 76. Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Thermo Fisher Scientific (US) Recent Development
Table 78. Agilent Technologies (US) Company Details
Table 79. Agilent Technologies (US) Business Overview
Table 80. Agilent Technologies (US) Digital Companion Diagnostics Product
Table 81. Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Agilent Technologies (US) Recent Development
Table 83. Life Technologies (US) Company Details
Table 84. Life Technologies (US) Business Overview
Table 85. Life Technologies (US) Digital Companion Diagnostics Product
Table 86. Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Life Technologies (US) Recent Development
Table 88. GE Healthcare (UK) Company Details
Table 89. GE Healthcare (UK) Business Overview
Table 90. GE Healthcare (UK) Digital Companion Diagnostics Product
Table 91. GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 92. GE Healthcare (UK) Recent Development
Table 93. Agendia (Angola) Company Details
Table 94. Agendia (Angola) Business Overview
Table 95. Agendia (Angola) Digital Companion Diagnostics Product
Table 96. Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Agendia (Angola) Recent Development
Table 98. Qiagen (Germany) Company Details
Table 99. Qiagen (Germany) Business Overview
Table 100. Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Qiagen (Germany) Recent Development
Table 102. Genomic Health (US) Company Details
Table 103. Genomic Health (US) Business Overview
Table 104. Genomic Health (US) Digital Companion Diagnostics Product
Table 105. Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Genomic Health (US) Recent Development
Table 107. Myriad Genetics (US) Company Details
Table 108. Myriad Genetics (US) Business Overview
Table 109. Myriad Genetics (US) Digital Companion Diagnostics Product
Table 110. Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Myriad Genetics (US) Recent Development
Table 112. Advanced Cell Diagnostics (US) Company Details
Table 113. Advanced Cell Diagnostics (US) Business Overview
Table 114. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product
Table 115. Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Advanced Cell Diagnostics (US) Recent Development
Table 117. Danaher (US) Company Details
Table 118. Danaher (US) Business Overview
Table 119. Danaher (US) Digital Companion Diagnostics Product
Table 120. Danaher (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 121. Danaher (US) Recent Development
Table 122. Applied Proteomics (US) Company Details
Table 123. Applied Proteomics (US) Business Overview
Table 124. Applied Proteomics (US) Digital Companion Diagnostics Product
Table 125. Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million)
Table 126. Applied Proteomics (US) Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Digital Companion Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Digital Companion Diagnostics Report Years Considered
Figure 12. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Digital Companion Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Digital Companion Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Digital Companion Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Digital Companion Diagnostics Market Share by Players in 2020
Figure 17. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2020
Figure 19. Global Digital Companion Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Digital Companion Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Digital Companion Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Digital Companion Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Digital Companion Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Digital Companion Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Digital Companion Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Digital Companion Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Digital Companion Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Digital Companion Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Digital Companion Diagnostics Market Share by Region (2016-2027)
Figure 41. China Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Digital Companion Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America Digital Companion Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America Digital Companion Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Digital Companion Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Digital Companion Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Digital Companion Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Holdings (Switzerland) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 61. Abbott Laboratories (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 62. Thermo Fisher Scientific (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 63. Agilent Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 64. Life Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 65. GE Healthcare (UK) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 66. Agendia (Angola) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 67. Qiagen (Germany) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 68. Genomic Health (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 69. Myriad Genetics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 70. Advanced Cell Diagnostics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 71. Danaher (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 72. Applied Proteomics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---